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Abstract: Hypothesis: Epithelial ion transport pathologies of the endolymphatic sac (ES) are associated
with large vestibular aqueduct syndrome (LVAS). Background: LVAS is defined by the pathognomonic
features of a widened bony vestibular aqueduct (VA) and an enlarged ES. The underlying cause of its
associated cochleovestibular symptoms remains elusive. Disturbances in epithelial ion transport in the
enlarged ES, affecting inner ear fluid regulation, were proposed as a possible pathophysiology. However,
although respective epithelial ion transport pathologies have been demonstrated in the enlarged ES from
transgenic LVAS mouse models, these pathologies have not been investigated in human LVAS cases.
Methods: Histological and immunohistochemical analysis of the enlarged ES epithelium in postmortem
temporal bones from two individuals with a clinical diagnosis of LVAS. Results: The enlarged ES epithe-
lium demonstrated an overall atypical epithelial differentiation and a lack of the immunolocalization of
signature ion transport proteins. Notably, in both cases, a rudimentary branch of the ES with a typically
differentiated ES epithelium was present. Conclusions: The described cellular and molecular pathologies
of the enlarged ES in humans provide evidence of epithelial transport pathology as one potential cause
of cochleovestibular symptoms in LVAS. The present findings also emphasize the clinical relevance of
already established LVAS mouse models.
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Hypothesis: Epithelial ion transport pathologies of the
endolymphatic sac (ES) are associated with large vestibular
aqueduct syndrome (LVAS).
Background: LVAS is defined by the pathognomonic fea-
tures of a widened bony vestibular aqueduct (VA) and an
enlarged ES. The underlying cause of its associated cochleo-
vestibular symptoms remains elusive. Disturbances in epithe-
lial ion transport in the enlarged ES, affecting inner ear fluid
regulation, were proposed as a possible pathophysiology.
However, although respective epithelial ion transport pathol-
ogies have been demonstrated in the enlarged ES from
transgenic LVAS mouse models, these pathologies have not
been investigated in human LVAS cases.
Methods: Histological and immunohistochemical analysis of
the enlarged ES epithelium in postmortem temporal
bones from two individuals with a clinical diagnosis of
LVAS.
Results: The enlarged ES epithelium demonstrated an over-
all atypical epithelial differentiation and a lack of the
immunolocalization of signature ion transport proteins. Nota-
bly, in both cases, a rudimentary branch of the ES with a
typically differentiated ES epithelium was present.
Conclusions: The described cellular and molecular patholo-
gies of the enlarged ES in humans provide evidence of
epithelial transport pathology as one potential cause of
cochleovestibular symptoms in LVAS. The present findings
also emphasize the clinical relevance of already established
LVAS mouse models. Key Words: Endolymphatic
hydrops—Enlarged vestibular aqueduct—Epithelial sodium
channel—Menière’s disease—Pendrin.
Otol Neurotol 41:xxx–xxx, 2020.
Large vestibular aqueduct syndrome (LVAS) is char-
acterized by the pathognomonic features of a widened
bony vestibular aqueduct (VA) and an enlarged endo-
lymphatic sac (ES) (1,2). Clinically, LVAS usually man-
ifests as sensorineural, mixed, or, rarely, purely
conductive hearing loss in early childhood and often
exhibits a fluctuating and progressive course (reviewed
in (3–5)). Concomitant vestibular symptoms ranging
from chronic disequilibrium to an episodic Menière’s-
like symptom complex can occur (6–9). The most fre-
quent causes of LVAS (10) are considered mutations in
the SLC26A4 gene (11,12), which encodes the anion
exchanger pendrin (13). In the human and murine inner
ear, pendrin is expressed by nonsensory cells in the
cochlea, the vestibular labyrinth, and the ES epithelium
(14,15). Notably, a lack of pendrin expression in the ES
(ES-specific pendrin knockout mice)—but not in the
cochleovestibular epithelia—leads to the development
of an inner ear phenotype that resembles LVAS
(reviewed in (16)). The pathophysiology that underlies
this LVAS phenotype in mice presumably involves a lack
of pendrin-dependent chloride and bicarbonate transport,
as well as secondarily diminished functions of the epi-
thelial sodium channel (ENaC (17)) and other ion trans-
port proteins (17–20). Although pendrin (21) and ENaC
(22) are present in the normal human ES epithelium, the
enlarged ES epithelium from LVAS patients has thus far
not been investigated for potential ion transport patholo-
gies. Here, we analyzed the epithelial morphology and
the immunohistochemical localization patterns of the
three ENaC subunits in the enlarged ES on histologically
processed temporal bone sections from two individuals
with a clinical diagnosis of LVAS. The results shed light
on the molecular pathologies in the human enlarged ES
epithelium and draw parallels to the molecular ion trans-
port pathologies in LVAS mouse models.
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METHODS
Human Temporal Bone Cases
The database of the human temporal bone (TB) collection at
the Massachusetts Eye and Ear Infirmary was searched with the
key words ‘‘enlarged/large vestibular aqueduct/endolymphatic
sac.’’ The search retrieved a total of eight cases. Two of those
cases (only one TB specimen was available from each case)
were included in the study because their enlarged VA and ES
were completely preserved and without any artifactual damage.
Computed tomography (CT) scans of the extracted specimens
were acquired before histological processing using dedicated
standard protocols for TB imaging. The specimens were histo-
logically processed according to previously described methods
(23). The temporal bone pathology in case #2 was recently
published (24), excluding the ES pathologies described here.
Morphometry of the VA
In each specimen, the diameter of the VA in the axial plane
was determined by measuring the maximum distance between
the two bony lips that form the operculum on CT images and
histological sections from corresponding images/section planes,
according to (25,26).
Immunohistochemistry
Celloidin sections were mounted on microscope slides, and
the celloidin was removed according to methods described
previously (27). The sections were blocked in 5% normal horse
serum (NHS) diluted in phosphate-buffered saline (PBS) and
incubated overnight with primary antibodies that were raised in
rabbit and directed against the a- (aENaC), b- (bENaC), and g-
(gENaC) subunits of the ENaC (a gift from Prof. J. Loffing,
University of Zurich). The sections were then incubated with
biotinylated secondary antibodies that were raised in donkey
and directed against rabbit IgG for 1 hour, followed by the
application of an avidin–biotin complex reagent (Jackson
ImmunoResearch,West Grove, PA) for 1 hour, an amplification
step that included incubation with biotinylated tyramine for
10minutes, and incubation with avidin–biotin complex reagent
for 30minutes. Then, all sections were incubated in diamino-
benzidine/hydrogen peroxide in PBS supplemented with 4%
3,30-diaminobenzidine (Sigma, St. Louis, MO) for 2 to 10
minutes. The slides were then dehydrated in an ascending
ethanol series, cleared with xylenes, and mounted for micro-
scopic analysis. All primary and secondary antibodies were
diluted in 1%NHS/PBS. All incubation steps were performed at
RT and followed by two 5minutes washes in PBS.
Microscopic Analysis
Images were acquired using an ACCU-Scope AU-600-HD
Excelis HD High Definition Color Microscopy Camera with
Live HDMI video (Accu Scope Inc., New York, NY) and




Case #1 (Table 1) was a 66-year-old male with a
clinical history of early-onset (age 8) bilateral sensori-
neural hearing loss, which, at age 44, had progressed to
severe levels. Before left cochlear implantation at age 47,
a CT scan demonstrated bilateral Mondini deformities
and bilateral large VAs. Postoperative fluctuations in
hearing and increased tinnitus were noted in the
implanted left ear, as well as at least two occasions of
nausea and dizziness. Retrospectively, the patient
reported some fluctuation in hearing and tinnitus earlier
in life. A tentative diagnosis of Menière’s syndrome was
made. At age 64, he underwent cochlear implantation in
the right inner ear. Two years later (age 66), the patient
developed bacterial meningitis, and the right cochlear
implant was removed in a canal wall-down mastoidec-
tomy procedure. He died a month later following a
cardiac catheterization procedure for coronary heart dis-
ease. The histopathological findings from the right TB
specimen included a shortened cochlear duct (1 1/4 turns)
with malformation of the apical and middle turns, con-
sistent with the radiographic diagnosis of incomplete
partition type 2 (hypoplastic modiolus, scala communis
in the apical turn (28)). The cochlear and vestibular
spaces were almost entirely filled with mature granula-
tion tissue. The cochlear implant track, which reached
from the cochleostomy site well into the scala vestibuli,
was lined with granulation tissue, cellular debris, and a
few foreign body giant cells. The scala tympani in the
basal turn was largely filled with new bone. CT imaging
(Fig. 1A) and histological examination of the right TB
(Fig. 1, B and B’) demonstrated a widened VA with an
axial diameter of 1.7mm, which was more than double
the diameter of the posterior semicircular canal (pSCC;
0.6mm), thus matching the different pathomorphological
criteria of an enlarged VA (e.g., opercular width
>1.5mm (25,26,29)).
Case #2 (Table 1) was an 18-year-old man diagnosed
with Kleefstra syndrome (microdeletion on chromosome
TABLE 1. Clinical and histopathological features of the two
LVAS cases
Feature Case #1 Case #2
Sex Male Male
Age at death (years) 66 18














Available TB specimen Right Left
Post mortem time (hours) 4 38.5





aAs measured in histological sections.
n.k. indicates not known; TB, temporal bone.
2 A. H. ECKHARD ET AL.
Otology & Neurotology, Vol. 41, No. xx, 2020
Copyright © 2020 Otology & Neurotology, Inc. Unauthorized reproduction of this article is prohibited.
9q34.3 (30,31)). His clinical symptoms included bilateral
mixed hearing loss, microcephaly, typical facial dys-
morphism, bilateral optic nerve hypoplasia with blind-
ness, diffuse hypotonia, dilated cardiomyopathy, chronic
lung disease secondary to microaspiration, and scoliosis.
After aortic valve replacement, he suffered from deteri-
orating cardiac function. At age 18, he was transferred to
a hospital with severe cardiac dysfunction and died after
unsuccessful resuscitation efforts. On histopathological
examination, the middle ear and mastoid appeared unre-
markable, except for a thickened posterior crus of the
stapes. In the cochlea, the modiolus was dysmorphic and
absent in the apical turn, which presented as scala
communis, indicating an incomplete partition type 2
(28). No signs of endolymphatic hydrops were visible
in the cochlea or vestibular portions. The number of
spiral ganglion cells in Rosenthal’s canal and the associ-
ated dendrites in the spiral lamina were markedly reduced
(approximately 34% of that determined by previous
quantifications in age-matched controls). No hair cells
were present in the lower basal turn of the organ of Corti.
The vestibular system also exhibited dysmorphic
FIG. 1. Computed tomography (CT) images (axial plane) showing the enlargedVA areas from case #1 (A) and case #2 (C). sSCC indicates
superior semicircular canal; hSCC, horizontal semicircular canal; pSCC, posterior semicircular canal; Ve, vestibule; IAC, internal auditory
canal. Hematoxylin-eosin-stained sections of the opercular region andES aswell as schematized histological structures from case #1 (B,B’)
and case #2 (D, D’). Measurements of the VA diameter at the operculum (‘‘opercular width’’) were performed according to previously
published methods (25,26) (1.7mm in (A), 1.3mm in (C)). The maximum radial diameter of the pSCC in both cases was determined to be
0.6mm (A,C; in (A) only the sSCC is shown, themeasurements of the pSCCwere performed in a different section plane). Scale bars: 1mm.
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changes, including dislocation of the cristae of the supe-
rior and lateral semicircular canals and macula utriculi in
the anterior/superior aspect of the vestibule. CT imaging
(Fig. 1C) and histological examination of the left TB
(Fig. 1D and D’) demonstrated that the VA had an
opercular width (1.3mm) more than double the diameter
of the posterior semicircular canal (0.6mm); thus, match-
ing at least one criterion for an enlarged VA (29).
Atypical Epithelial Cell Morphology in the Enlarged
ES
In both cases, the ES, particularly the extraosseous ES
(eES) portion, which stretches from the operculum into
the dura of the posterior cranial fossa, demonstrated a
single, cyst-like, enlarged lumen (Fig. 1, B and D). This
luminal space was partially filled with cells and an
eosinophilic amorphous substance. Its epithelial lining
consisted predominantly of an atypical squamous epithe-
lium with interspersed patches of cuboidal or columnar
epithelial cells (Fig. 2,A and E). Notably, in both cases, a
small branch of the eES presented a normal-sized lumen,
the epithelium of which consisted of typical uniform,
cuboidal cells (Fig. 2, C and G).
Absence of Signature Ion Transport Proteins in the
Enlarged ES
Immunolabeling for the aENaC, bENaC, and gENaC
subunits was performed on celloidin-embedded sections
from the two LVAS cases. The epithelium of the enlarged
eES was virtually devoid of any specific immunolabeling
for the three ENaC subunits (Fig. 2, B and B’’ (case #1),
and F–F’’ (case #2)). In contrast, the portion of the eES
branch, which exhibited typical homogenous cuboidal
epithelium and normal sized lumen (see the previous
paragraph), demonstrated strong immunolabeling for all
ENaC subunits in many cells (Fig. 2D–D’’ (case #1), and
H–H’’ (case #2)). The immunolabeling signals for
gENaC and bENaC were often polarized toward the
apical membrane domain, while aENaC immunolabeling
was homogenous throughout the cytoplasm. These
immunolabeling patterns are consistent with those pre-
viously described in the normal human eES (32). As an
internal positive control, immunolabeling for all three
ENaC subunits was also detected in the apical cell
membranes and the cytoplasm of the middle ear epithe-
lium (data not shown (33)).
Inflammatory Cell Infiltration in the Enlarged ES
In the dural tissue surrounding the enlarged eES, large
numbers of immune cells, predominantly polymorpho-
nuclear leukocytes and macrophages, were found in both
cases (Fig. 3,A and B). These inflammatory cells accu-
mulated in scattered focal areas in the subepithelial
space, appeared to transmigrate across the ES epithelial
border (inlay, Fig. 3B), and presented in unusual density
in the luminal space. Large numbers of luminal and
perisaccular cells were identified as macrophages based
on their positive immunolabeling for calcium-binding
adapter molecule 1 (IBA1; Fig. 3, C and D). IBA1
immunolabeling in a normal eES (adult control case)
is provided for comparison (Fig. 3E). Although the
history of cochlear implantation and meningitis in case
#1 may constitute a confounder in the present analysis,
very similar proinflammatory immune cell patterns were
identified in case #2, despite the lack of such confound-
ing factors according to the clinical records.
On note, the histo- and immunopathologies in the
enlarged ES from a third LVAS case were recently
presented at the Otopathology conference, hosted at
the Massachusetts Eye and Ear (Boston, MA). A webcast
of this presentation is available online (http://otopatho-
logylaboratory.org/educational-resources/webcasts/?).
The findings in this third case were very similar to those
reported here for cases #1 and #2, and further support our
conclusions (see Discussion section).
DISCUSSION
The most common causes of LVAS are mutations in
the SLC26A4 gene, which encodes the chloride (Cl)/
bicarbonate (HCO3
) exchanger pendrin; these muta-
tions are found in up to 90% of patients (34–36). Pendrin
is expressed in different cell types in the human and
murine inner ear, including spiral prominence cells and
outer sulcus cells in the cochlear spiral ligament (15,37),
transitional cells in the utricle, saccule and ampullae
(14,37), and mitochondria-rich epithelial cells in the
ES (14,15).
Among the inner ear epithelia, the ES is a particularly
critical site for pendrin function. Targeted disruption of
pendrin gene expression in the ES of Foxi1 knockout
(Foxi1/) mice causes an inner ear phenotype that
resembles LVAS in humans (38). A key pathogenetic
event in the pendrin-deficient murine inner ear is a
reduction in endolymph pH (acidification) due to the
loss of pendrin-mediated HCO3
– transport (18). Endo-
lymph acidification diminishes ENaC gene expression in
the inner ear epithelia (19), and probably inhibits the
resorption of endolymphatic Naþ. This effect is thought
to cause sodium chloride (NaCl) retention and osmotic
volume expansion of the endolymphatic fluid compart-
ment, which ultimately determine the pathomorpholog-
ical features of the LVAS phenotype, i.e., enlargement of
the ES and VA and the development of cochleovestibular
hydrops (19,20). Moreover, endolymph acidification
may also inhibit the pH-sensitive transient receptor
potential subfamily V (TRPV) members TRPV5 and
TRPV6, which are also expressed in different epithelial
cell types in the inner ear, including the endolymphatic
sac (39–42). Inhibition of TRPV5 and TRPV6 may
explain the pathological increase in endolymphatic
Ca2þ (40), which is thought to disturb hair cell function
(43,44), and thus may play an important role in the
pathogenesis of cochleovestibular symptoms in LVAS
mouse models (40).
Here, we demonstrate the overall absence of immu-
nolabeling for all three ENaC subunits in the enlarged
human ES. This finding clearly contrasts the presence of
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FIG. 2. Representative epithelial morphology in the enlarged ES (A and E) and the rudimentary ‘‘normal’’ portion of the eES (C and G) in
cases #1 and #2. Immunolabeling of a-, b-, and gENaC in enlarged ES (B–B’’, F–F’’) and ‘‘normal’’ eES (D–D’’, H–H’’) portions from both
cases (black arrows indicate ENaC-labeled epithelial cells). Scale bars: 10mm.
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abundant ENaC in the normal human eES described
previously (32). However, it is consistent with dimin-
ished ENaC expression in the inner ears from LVAS
mouse models (see the previous paragraph). The cause of
the lack of ENaC in the enlarged human ES remains
unknown from our study but could be either a primary
(its absent expression in an abnormally differentiated
enlarged ES epithelium) or secondary (expression down-
regulation caused by altered endolymph fluid composi-
tion, e.g., acidification) pathology. Finally, the presence
of a variably sized, rudimentary eES portion with a
typical epithelial morphology, strong ENaC immunolab-
eling, and presumably normal ion transport capabilities,
may affect the manifestation and progression of cochle-
ovestibular dysfunction in LVAS, and thus help to
explain the heterogeneous clinical presentations among
patients.
In summary, the present findings suggest a common
underlying epithelial transport pathology in the enlarged
ES epithelium that affects endolymphatic osmoregula-
tion and volume regulation in both animal models and
LVAS patients.
FIG. 3. Massive accumulation of inflammatory cells at the epithelial border of enlarged ES portions in cases #1 (A) and #2 (B). IBA1
immunolabeling identified many luminal and subepithelial cells as macrophages, particularly those that appear to transmigrate across the
ES epithelial barrier (arrows in (C) (case #1) and (D) (case #2)). IBA1 immunolabeling in the ES froma normal (no history of otologic disease)
control case (E). Scale bars: 100mm; inset (B), 10mm.
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Notably, in a recent histopathological study on
Menière’s disease, we described two epithelial patholo-
gies—idiopathic epithelial degeneration and develop-
mental hypoplasia—both of which affect the eES and
are associated with the loss of eES-specific ion transport
proteins, including ENaC (32). Apart from their different
sizes, the hypoplastic ES of Menière’s patients (32,45)
and enlarged ES in LVAS patients have strikingly similar
hallmark pathological features: 1) a cyst-like (single
lumen) ES, 2) mostly squamous-like epithelium, 3)
markedly reduced (absent) ENaC protein abundance,
and 4) abnormal morphology of the bony VA (widened
in LVAS, narrowed in Menière’s disease). Thus,
although different etiologies may lead to enlargement
or hypoplasia of the ES, the pathophysiological conse-
quences may be very similar, which would explain the
Menière’s-like clinical features that are often reported in
many LVAS patients (such as case #1 in the present
study); these features include cochleovestibular hydrops
((46,47); not conclusively analyzed in the two present
cases; see Results section), fluctuating progressive sen-
sorineural hearing loss, and episodic dizziness/vertigo
(2,3,7,48). As a side note, the air-bone gap commonly
observed in LVAS patients is best explained by a patho-
logic third window effect of the widened VA (49). The,
often rapid, progressive sensorineural hearing loss is
most likely due to the degeneration of neurosensory
structures, which may be a consequence of, e.g., the
here-proposed ES dysfunction or other ion transport
pathologies within the inner ear, or the structural cochlear
partitioning defect, or a combination of these patholo-
gies.
An ambiguous finding of the present study is the
massive infiltration of immune cells, mostly IBA1þ
macrophages, in the ES luminal space, and the perisacc-
ular region. This proinflammatory pattern is unlikely to
be a postmortem artifact since, at least in case #1, the
time from death to formalin fixation was as short as 4
hours (38.5 h in case #2). Some possible causes that could
explain this local immune cell recruitment include a
reduced pH (acidification (50)) and an elevated Naþ
concentration (51) in the enlarged ES; thus, this finding
may be directly linked to the impaired ion transport
capabilities of the ES epithelium.
A limitation of the present study is the unknown
SLC26A4 genotype in both cases, which raises the
question of whether the reported findings can be
generalized to a broader LVAS population. However,
that very similar (immuno)histopathologies were pres-
ent in both cases, although they represented categori-
cally different forms of LVAS—nonsyndromic (case
#1) and syndromic (case #2 associated with Kleefstra
syndrome) —argues for the broad relevance of the
present findings. Moreover, in addition to ENaC, the
enlarged ES epithelium may lack other crucial ion
transport proteins, which were not analyzed in the
present study, mainly due to the impediment of the
limited antigenicity of the archival celloidin-embedded
tissue sections.
In conclusion, the present findings support the concept
of an epithelial transport pathology in the enlarged ES as
an etiopathogenetic factor for LVAS. Furthermore, we
propose that certain cellular and molecular ES patholo-
gies are shared between patients with LVAS and those
with Menière’s disease (endotype with ES hypoplasia),
which may explain the similar, and often overlapping,
clinical features in these two patient groups. In both
LVAS and Menière’s disease, the bony abnormalities
of the VA associated with LVAS (VA widening) and
Menière’s disease (VA hypoplasia) may be regarded as
‘‘fossil-like records’’ (52) of the underlying epithelial
pathologies, the former of which serve as radiological
surrogate markers (48,53). Lastly, the present findings
draw parallels to the pathophysiology of LVAS mouse
models and thereby help validate those models as impor-
tant research tools in which to study the human condition.
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